erdafitinib
janssen
['ragnar']
ragnar: erda in fgfr+ (muts and fusions) for heavily pretreated patients. orr 29.2%, dcr 75.3%, dor 7.1 mo, mpfs 5.2 mo, mos 10.9 mo. median of 2 previous treatments and 40% of hard to treat patients (cholangio, gliomas, pancreas). glad to be part of this! #asco22
Husband, Father.
Medical Oncologist and Researcher focused in Thoracic Oncology.
Views are my own.